MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orthotics. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 million ($2.75 million) and SEK150 million ($16.51 million) with enterprise value SEK50 million ($5.90 million) and SEK250 million ($23.06 million) and sales value between €5 million ($5.43 million) and €25 million ($27.18 million) and EBITDA between SEK1 million ($0.11 million) and SEK50 million ($5.50 million). The firm seeks to takes both minority and majority stakes. It uses its capital and loans and makes balance sheet investments. The company was founded in 2001 and is based in Stockholm, Sweden.